- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 114-128 of
326 results
No. 2-10
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-10 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-19
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-19 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-4
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-4 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-13
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-13 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-18
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-18 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-17
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-17 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-7
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-7 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-15
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-15 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-5
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-5 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-11
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-11 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-16
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-16 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-8
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-8 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-14
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-14 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-6
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-6 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-1
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-1 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
